Home / Recalls / Adamis Pharmaceuticals Corporation / D-0764-2022

D-0764-2022 Class I Terminated

Recalled by Adamis Pharmaceuticals Corporation — San Diego, CA

Recall Details

Product Type: Drugs
Report Date: April 13, 2022
Initiation Date: March 21, 2022
Termination Date: February 8, 2023
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 2,500 cartons

Product Description

SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-131-02.

Reason for Recall

Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.

Distribution Pattern

Nationwide in the U.S.A.

Code Information

Lot # 21101Y, Exp. 11/30/2022